Posts for Category: ACMT News

ACMT was recently awarded a five-year, $1 million cooperative agreement with the Centers for Disease Control (CDC) to implement the “Strengthening the Public Health System and Services through a Capacity Building Assistance Program for Medical Toxicologists.”

Thank you to everyone who joined us in Denver for the 2024 North American Congress of Clinical Toxicology (NACCT) from September 19-23, 2024! ACMT was proud to host a series of thought-provoking and dynamic sessions throughout the event.

ACMT is pleased to announce that William "Russ" Kerns, II, MD, FACMT, FACEP, will receive the 2025 ACMT Career Achievment Award and deliver the Career Achievment Address at the 2025 ACMT Annual Scientific Meeting in Vancouver, Canada, next April.

ACMT Member Sonya Rashid, MD discusses the dangers of caffeine overdose in young people.

ACMT is pleased to announce it has been named a recipient of a new five-year cooperative agreement with the CDC as part of the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health program.

ACMT continues to work hard to advance our specialty and support you. Our unwavering commitment to steady growth is evident in the positive impact to our patients and health care overall.

ACMT's ToxIC Fentanyl Analog Study has detected medetomidine in patients seen in the ED after suspected opioid overdose. Data from this study included in a Morbidity and Mortality Weekly Report (MMWR) released by the CDC.

ACMT recently concluded its 2024 Annual Scientific Meeting in Washington, DC. Marking another milestone year, the event shattered attendance records with 444 participants hailing from 41 states and 16 different countries.

This annual award is given to honor a member of the ACMT Education Committee who has displayed excellence in establishing and promoting ACMT's educational program and who has distinguished themself with volunteer service to the committee. The 2024 ACMT Education Committee Service Award goes to Dr. Gillian Beauchamp.

We congratulate Forrest Mahoney, MD, who received the funding for his proposed project on "Detecting Harmful Algal Blooms (HABs) in New England Sea Turtles."